Allogeneic bone marrow transplantation is a therapeutic option for enzyme replacement in children with lysosomal storage diseases, for which no current conventional treatments are curative. Although marrow allografting is costly, intensive, and not risk free, strides are being made in the management and prevention of procedure-related complications.
|Original language||English (US)|
|Number of pages||5|
|Journal||Maryland medical journal (Baltimore, Md. : 1985)|
|State||Published - Apr 1990|
ASJC Scopus subject areas